The Relationship between Depressive Symptoms, Anxiety and Sociodemographic Characteristics in Individuals with Chronic Diseases

Abstract

Purpose: This study aims to reveal the relationship between depressive symptoms, anxiety level and socio-demographic characteristics of individuals with chronic diseases. Methods: The study sample consisted of 149 individuals over the age of 18 who agreed to participate in the study and had a chronic disease. Each of the participants completed a questionnaire that revealed their socio-demographic characteristics, a Beck Depression Inventory and a Generalized Anxiety Inventory-7. Results: The participants’ mean BDI score was 14.56±10.08 and the average score of GAD-7 test was 7.40±5.57. 34% of the patients are at risk of moderate and 8.7% at risk of severe depression. 22.8% of individuals are under high and 11.4% under serious anxiety threat. Average total scores of depression and anxiety scales are significantly higher in those with lower incomes than normal or higher incomes and in singles when compared to married people. In addition, the GAD-7 test scale mean score of those who did not comply with the treatment was higher. In addition, a positive linear relationship was found between BDI and GAD-7. Conclusions: Depression and anxiety levels are significantly higher in patients with chronic disease. It is recommended that, individuals at risk among those with chronic diseases should be identified and supported psycho-socially.

Keywords

• Chronic disease
• depression
• anxiety

References

1. 1. Muttoni S, Ardissino M, John C. Classical psychedelics for the treatment of depression and anxiety: Asystematic review, Journal of Affective Disorders 2019; 258: 11-24.
2. 2. Mao Y, Zhang N, Liu J, Zhu B, He R, Wang X. A systematic review of depression and anxiety in medical students in China, BMC Medical Education 2019;19:327: 1-13.
3. 3. Ergöl Ş, Kuzu A. 15-49 yaş evli kadınlarda depresyon ve anksiyete belirtileri ile evlilik özelliklerinin ilişkisi. International Journal of Human Sciences 2016; 13(1): 1023-1035.
4. 4. Türkçapar H. Anksiyete bozukluğu ve depresyonun tanısal ilişkileri. Klinik Psikiyatri 2004; Ek 4: 12-16.
5. 5. Chen J, Bai S, Li W, Zhou C, Zheng P, Fang L, Wang H, Liu Y & Xie P. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Translational Psychiatry 2018; 8(192): 1-10.
6. 6. Tiller JWG. Depression and anxiety, MJA Open 2012;1(Suppl 4):28–32.
7. 7. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147–55.
8. 8. Creed F, Morgan R, Fiddler M et al. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002; 43: 302–9.

9. 9. Ertekin Pınar Ş, Tel H. Depresyon tanılı birey ve hemşirelik yaklaşımı. Psikiyatri Hemşireliği Dergisi 2012; 3(2): 86-91.
10. 10. Herring MP, Puetz TW, O’Connor PJ, Dishman RK. Effect of exercise training on depressive symptoms among patients with a chronic ıllness. Arch Intern Med 2012; 172(2): 101-11.
11. 11. Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Jaime Miranda J, Bullinger M, Steptoe A, Whooley MA, Otte C. Comorbid depression in medical diseases 2020; 6(69): 1-22.
12. 12. Mete HE. Kronik hastalık ve depresyon, Klinik Psikiyatri 2008; 11(Ek 3): 3-18.
13. 13. Uslu H. Kalp yetersizliği olan hastaların ve bakımverenlerin anksiyete-depresyon düzeyleri ve yaşam kalitelerinin belirlenmesi. [Yüksek Lisans Tezi] Antalya: Akdeniz Üniversitesi; 2011.
14. 14. Niles AN, Dour HJ, Stanton AL, Roy-Byrne PP, Stein MB, Sullivan G, Sherbourne CD, Rose RD, Craske MG. Anxiety and depressive symptoms and medical illness among adults with anxiety disorders, Journal of Psychosomatic Research 2015; 78(2): 109-15.
15. 15. Akın S, Durna Z. Kalp yetersizliği hastalarının psikososyal uyumu. Cumhuriyet Üniversitesi Hemşirelik Yüksekokulu Dergisi 2006; 10(2): 1-8.
16. 16. Karacan Y, Kapucu SS. Periferik kök hücre naklinde hastalarda görülen anksiyete ve depresyon. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi 2010; 13(1): 77-82.
17. 17. Oflaz F, Varol H. Yatan hastaların anksiyete ve depresyon düzeyleri ve ilişkili faktörlerin incelenmesi. S.D.Ü. Tıp Fak. Derg 2010; 17(1): 1-7.
18. 18. Özdemir Ü. ve Taşcı S, Kronik hastalıklarda psikososyal sorunlar ve bakım, Erciyes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2013; 1(1): 57-72.
19. 19. Kökcü ÖD, Güler DS, Sipahi S, Öztop KE. Kronik böbrek yetmezliği hastalarının glomerüler filtrasyon değerinin bağımsız değişkenler ile yordama gücü. Sakarya Tıp Dergisi 2019; 9(3): 412-9.
20. 20. Watkins LL, Koch GG, Sherwood A, Blumenthal JA, Davidson JRT, O’Connor C, et al. Association of anxiety and depression with all-cause mortality in ındividuals with coronary heart disease. Journal of the American Heart Association 2013; 2:e000068.
21. 21. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations. A Scientific Statement From the American Heart Association 2014; 129: 1350–69.
22. 22. Uhlenbusch N, Löwe B, Härter M, Schramm C, Weiler-Normann C, et al. Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLOS ONE 2019; 14(2): e0211343.
23. 23. Stubbs B, Aluko Y, Myint PK, Smith TO. Prevalence of depressive symptoms and anxiety in osteoarthritis: a systematic review and meta-analysis, Age and Ageing 2016; 45: 228–35.
24. 24. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013; 52: 2136–48.
25. 25. Yeşilbalkan ÖU, Akyol AD, Çetinkaya Y. ve ark. Kemoterapi tedavisi alan hastaların tedaviye bağlı yaşadıkları semptomlar ve yaşam kalitesine olan etkisinin incelenmesi. Ege Üniversitesi Hemşirelik Yüksek Okulu Dergisi 2005; 21(1): 13-31.
26. 26. Bahar A, Sertbaş G, Sönmez A. Diabetes mellituslu hastaların depresyon ve anksiyete düzeylerinin belirlenmesi. Anadolu Psikiyatri Dergisi 2006; 7: 18-26.
27. 27. Blumenthal JA, Babyak MA, O’Connor C. Effects of exercise training on depressive symptoms in patients with chronic heart failure: The HF-ACTION randomized trial. JAMA 2012; 308(5): 465- 74.
28. 28. Faul F, Erdfelder E, Buchner A, Lang A. Statistical Power Analyses Using G*Power 3.1: Tests for Correlation and Regression Analyses. Behavior Research Methods 2009; 41(4): 1149–60.
29. 29. Hisli N. Beck Depresyon Envaterinin Üniversite öğrencileri için geçerliği, güvenirliği J Psychol 1989; 7: 3-13.
30. 30. Konkan R, Şenormancı Ö, Güçlü O, Aydın E, Sungur MZ. Yaygın anksiyete bozukluğu-7 (YAB-7) testi Türkçe uyarlaması, geçerlik ve güvenirliği, Nöropsikiyatri Arşivi 2013; 50: 53-8.
31. 31. Lindenberg K, Kindt S, Szász-Janocha C. Internet Addiction in Adolescents: The PROTECT Program for Evidence-Based Prevention and Treatment 2020;297.
32. 32. Acharya, CP, Poudel K, Thapaliya R. Anxiety and depression among patients with chronic obstructive pulmonary disease and general population in Rural Nepal. BMC Psychiatry 2020; 17(1): 35–44.
33. 33. Abu Ameerh MA, Hamad GI. The prevalence of depressive symptoms and related risk factors among diabetic patients with retinopathy attending the Jordan university hospital. European Journal of Ophthalmology 2021; 31(2): 529–35.
34. 34. Albasara SA, Haneef MS, Zafar M, Moinuddin KG. Depression and associated risk factors among hypertensive patients in primary health care centers in Dammam, Kingdom of Saudi Arabia. Pan African Medical Journal 2021; 38: 1-9.
35. 35. Westhoff-Bleck M, Winter L, Aguirre Davila L, Herrmann-Lingen C, Treptau J, Bauersachs J, Bleich S, Kahl KG. Diagnostic evaluation of the hospital depression scale (HADS) and the Beck Depression Inventory II (BDI-II) in adults with congenital heart disease using a structured clinical ınterview: ımpact of depression severity. European Journal of Preventive Cardiology 2020; 27(4): 381–90.
36. 36. Zhou X, Shi H, Yang Y, Zhang Z, Zhai Z, Wang C. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: results from a Chinese survey.” Experimental and Therapeutic Medicine 2020; 3124–32.
37. 37. Moonajilin S, Rahman E, Islam S. Relationship between overweight/obesity and mental health disorders among bangladeshi adolescents: A cross-sectional survey. Obesity Medicine 2020; 18: 100216.
38. 38. Muscat P, Weinman J, Farrugia E, Callus R, Chilcot J. Illness perceptions predict distress in patients with chronic kidney disease. BMC Psychology 2021; 9(1): 1–13.
39. 39. Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, Bressler B. Prevalence of anxiety and depression in patients with inflammatory bowel disease. Canadian Journal of Gastroenterology and Hepatology 2017; 1-6.
40. 40. Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, Fradelos EC. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pacific Journal of Cancer Prevention 2018; 19(6): 1661–9.
41. 41. Jimenez-Fonseca P., Calderón C, Hernández R, y Cajal TR, Mut M, Ramchandani A, Donnay O, Carmona-Bayonas A. Factors associated with anxiety and depression in cancer patients prior to ınitiating adjuvant therapy. Clinical and Translational Oncology 2018; 20(11): 1408–15.
42. 42. Mols F, Schoormans D, de Hingh I, Oerlemans S, Husson O. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES registry: prevalence, predictors, and ımpact on quality of life. Cancer 2018; 124(12): 2621–8.
43. 43. Zhong R, Chen Q, Li M, Li N, Zhang X, Lin W. Sex differences in anxiety in patients with epilepsy: Status and risk factors analysis. Epilepsy and Behavior 2021; 116: 107801.
44. 44. Erşan EE, Şencan D, Gürbüz HC, Deveci H, Karadağ A. Fibromiyaljili Hastaların Anksiyete Düzeylerinin İncelenmesi. Sempozyum 2011; 32: 32–9.
45. 45. Lim SW, Shiue Y, Ho C, Yu S, Kao P, Wang J, and Kuo J. Anxiety and depression in patients with traumatic spinal cord ınjury: a nationwide population-based cohort study. PLoS ONE 2017; 12(1): 1–14.
46. 46. Lan B, Jiang S, Li T, Sun X, Ma F. Depression, anxiety, and their associated factors among chinese early breast cancer in women under 35 years of age: a cross sectional study.” Current Problems in Cancer 2020; 44(5): 100558.
47. 47. Çelik HC, Acar T. Kronik hemodiyaliz hastalarında depresyon ve anksiyete düzeylerinin çeşitli değişkenlere göre incelenmesi. Fırat Tıp Dergisi 2007; 12(1): 23–7.
48. 48. Hacıhasanoğlu R, Karakurt P, Yıldırım A, Uslu S. Bir sağlık ocağına başvuran kronik hastalığı olan bireylerde anksiyete ve depresyon. TAF Prev Med Bull 2010; 9(3): 209–16.
49. 49. Dogru Huzmeli E, Sarac ET. Examination of sleep quality, anxiety and depression in stroke patients. Turkish Journal of Cerebrovascular Diseases 2017; 23(2): 51–5.
50. 50. Yıldız E, Kılınç G. Karaciğer nakli olan bireyleirn anksiyete, depresyon ve psikolojik dayanıklılıkları arasındaki ilişki. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi 2021; 9(2): 554–65.